MedTrace Logo

Effect of a Synergistic Food Basket on Metabolic Syndrome Risk

NCT01527253 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2014-05-23

No results posted yet for this study

Summary

The study evaluates the effect of a diet combining two different functional concepts on markers associated to cardiometabolic risk. The functional concepts are selected on the basis of their reported ability to influence the inflammatory tonus. It is hypothesized that the medium-term consumption of a diet combining low GI-prebiotic foods may positively influence various biomarkers associated with the risk for developing metabolic syndrome and cardiometabolic disease. Also, the combination of functional mechanisms are expected to result in synergistic effects.

Conditions

Interventions

OTHER

Synergistic food basket

A low glycemic index diet enriched in dried legumes and wholegrain cereals is compared with a control regime lacking these functional ingredients for their ability to ameliorate different markers associated with the risk for developing cardiometabolic disease

Sponsors & Collaborators

  • Anti-Diabetic Food Centre

    collaborator OTHER

  • Lund University

    lead OTHER

Principal Investigators

  • Inger Björck, PhD Prof. · Antidiabetic Food Centre, Lund University

  • Juscelino Tovar, PhD · Antidiabetic Food Centre, Lund University

  • Anne Nilsson, PhD · Lund University

  • Maria Johansson, PhD · Antidiabetic Food Centre, Lund University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-05-31
Completion
2012-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01527253 on ClinicalTrials.gov